In a xenograft model, treatment with the EGFR-targeted doxorubicin/photosensitizer-loaded nanoparticles, followed by NIR laser irradiation, led to an impressive result: complete regression of the tumor, at least for the duration of the experimental evaluation (14 days). The gene discussed is EGFR; the disease is neoplasm.